Identification of a novel crizotinib-sensitive NR-110219 & MIR 4432-ALK gene fusion in a patient with lung adenocarcinoma by high-throughput sequencing of circulating tumor DNA and tumor-derived DNA from pleural effusion fluid

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE(2018)

引用 0|浏览0
暂无评分
摘要
We found a novel NR-110219 & MIR4432-ALK gene fusion in a lung adenocarcinoma patient by highthroughput sequencing of circulating tumor DNA and tumor-derived DNA from pleural effusion fluid and the patient responded well to crizotinib.
更多
查看译文
关键词
Lung adenocarcinoma, NR-110219 & MIR4432-ALK gene fusion, ctDNA, crizotinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要